Somatic PIK3CA mutations as a driver of sporadic venous malformations. - Wikidata - thesis-toulmin - TriplyDB

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

http://www.wikidata.org/entity/Q37130685

about

Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems Targeting PI3K in cancer: impact on tumor cells, their protective stroma, angiogenesis and immunotherapy Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies.CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).Class (I) Phosphoinositide 3-Kinases in the Tumor Microenvironment.PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts.Therapeutic targeting of the angiopoietin-TIE pathway.Vascular heterogeneity and specialization in development and disease.Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.Venous malformations: PIK3CA mutations guide new treatments.PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.Efficient isolation and culture of endothelial cells from venous malformation using the Rho-associated protein kinase inhibitor Y27632.The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.mTORc1 activity is necessary and sufficient for phosphorylation of eNOSS1177.Cancer-Associated PIK3CA Mutations in Overgrowth Disorders Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility

P2860

Q28070234-69E048CA-250C-4AAD-80DC-7F905D71F9C8 Q29248893-9C152169-4B2C-402B-9479-32C19AAA078B Q36117648-974BCF0C-76F3-4EFE-A8E5-789E24B12D7D Q38899877-619E2BAA-6129-4E29-AE1F-27720B2C7223 Q39168810-DB7F7495-4EDC-4EF0-B3F2-29BEC904414D Q39206695-D0C58A7E-F306-464B-8762-95A67030519B Q39321127-0E3522EA-7EC8-4C8B-8E41-C0C2E9E5054D Q39326100-D01CF560-24E5-4CAE-97BE-59824A3C78D2 Q39875938-6589782D-6C3A-490B-890A-13646583A735 Q42331562-E019DF2E-2998-457D-B8F8-BD980B1A239C Q48204602-018992B5-91FA-43E9-AA32-BA82F4158805 Q50973335-DAA2268D-8604-4D42-9509-BFBF6021DB77 Q55435506-A5EC1873-FB23-4504-9370-29A64B476092 Q55497833-3D1BED4F-4C24-4F92-B5AE-CD24ABE1D386 Q58035745-B0763C8E-2B3E-40A9-BA8A-485C38D1E8EA Q59128909-BF4F5999-CF04-4C07-9B40-640568D8F0F8

P2860

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

http://www.wikidata.org/entity/Q37130685

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

@en

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

@nl

type

label

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

@en

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

@nl

prefLabel

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

@en

Somatic PIK3CA mutations as a driver of sporadic venous malformations.

@nl

P1433

Q37130685-D8B02C6E-829E-4C30-B4BF-595BA1D71AFC

P1476

Q37130685-DD14B852-A1AE-471D-84DE-2EE045045422

P2093

Q37130685-4387B68D-07EF-4990-B122-09997B0E24A6

Q37130685-4C4920D4-764B-4D29-9C26-FA61A4640395

Q37130685-52FBB8F6-F3EB-4D1D-AF62-070910E9C278

Q37130685-803FC836-A9F5-4ABB-80E8-5E758DE66C4D

Q37130685-958E2178-BE57-4C3B-830A-C1E65368DD82

Q37130685-A1E8E09C-FFCB-406A-96E2-FDDC69468552

Q37130685-B6199343-084C-4820-8354-BD56661B6B88

Q37130685-B79E3DDE-C37F-4BB9-87A0-23A97C77D67D

Q37130685-C969A06E-FEE0-416C-A7C6-B61F7B3FFA5B

P2860

Q37130685-00FFADD9-AEBB-4133-B24B-D522318F6ED2

Q37130685-0112BD3F-2CAF-4EC5-A3D5-6C82AD189170

Q37130685-01AAD42C-4058-43A0-834D-C13F207D2DA7

Q37130685-076C0DF6-3ED7-4E45-9473-492710A15442

Q37130685-0AB96928-59B0-4108-AB7E-1FC959714CD1

Q37130685-0B33E5ED-1328-438A-8BB7-5CBC9299888F

Q37130685-0E164171-E6C7-4ED4-8BD1-054218C785CE

Q37130685-0FE75620-EDDC-4BA0-98E4-36EF42638C4D

Q37130685-159A7391-DAD1-4BF7-9216-B071A8879AF7

Q37130685-1615C3E4-DFA7-4CF8-B0A6-238D25C7306D

P304

Q37130685-109980F3-D578-491C-922C-D284A5C3B835

P31

Q37130685-D8149B05-8D61-46F6-AE59-0C2FCE9D1EA4

P356

Q37130685-EA38ADBA-B28B-41E0-9907-3E8A3B1C095C

P407

Q37130685-8A7F1F68-F671-4A76-8B6B-13F2C10AD24C

P433

Q37130685-61F954DD-AF93-4EEC-9AAD-65C34C5A13B0

P478

Q37130685-E06A9836-B8F7-4E80-ABC2-7485ECFAF3DA

P50

Q37130685-1444DC41-08B8-48E8-9FC4-7C94EFFE8051

Q37130685-2272446A-15D1-4F5E-93E8-DC7EB2795615

P577

Q37130685-474D9CEA-9E8C-4CB8-B1C9-4D8685803BCF

P698

Q37130685-193B1626-5B85-4D5D-88E9-F0333EED3812

P932

Q37130685-4BFEDEEE-D540-442C-B69A-3A87D58876BC

P356

SCITRANSLMED.AAF1164

P1433

Science Translational Medicine

P1476

Somatic PIK3CA mutations as a driver of sporadic venous malformations

@en

P2093

Agnès Viale

http://www.w3.org/2001/XMLSchema#string

Cristina R Antonescu

http://www.w3.org/2001/XMLSchema#string

Eulàlia Baselga

http://www.w3.org/2001/XMLSchema#string

F Javier Carmona

http://www.w3.org/2001/XMLSchema#string

José Baselga

http://www.w3.org/2001/XMLSchema#string

Kathryn V Anderson

http://www.w3.org/2001/XMLSchema#string

Maurizio Scaltriti

http://www.w3.org/2001/XMLSchema#string

Michael F Berger

http://www.w3.org/2001/XMLSchema#string

Silvia Bague

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

A mosaic activating mutation in AKT1 associated with the Proteus syndrome

Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome

De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA

Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

Vascular anomalies: from genetics toward models for therapeutic trials

P304

332ra42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.AAF1164

http://www.w3.org/2001/XMLSchema#string

P407

P433

332

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Joaquim Grego-Bessa

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27030594

http://www.w3.org/2001/XMLSchema#string

P932

4962922

http://www.w3.org/2001/XMLSchema#string